| Market Cap | ₹172Cr |
| ROE | 11.38% |
| P/E Ratio(TTM) | 6.56 |
| EPS(TTM) | 12.47 |
| P/B Ratio | 1.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.57 |
| Book Value | 81.48 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
| Parent Organisation | Alpa Laboratories |
| Managing Director | Mr. Paresh Chawla |
| NSE Symbol | ALPA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 82.27 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.89 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.53 | ||
| Wockhardt | NA (0.00%) | -426.40 |